High Q Technologies Expands Quantum Protein Analysis Platform For Alz…

High Q Technologies has expanded its quantum-enabled electron paramagnetic resonance (EPR) platform, Fathom, for accelerated drug discovery in Alzheimer's and neurodegenerative diseases by capturing multiple protein configurations simultaneously. The company has partnered with contract research organization Creative Biostructure to broaden global access to the technology. If you're selling structural biology tools or running a CRO, you've just lost your monopoly on protein dynamics data. High Q's partnership with Creative Biostructure puts quantum EPR into 3,000 pharma labs within months—your customers now have a faster path to early-stage insights, which means they'll demand the same speed from you or leave.